Perimeter Medical files PMA application for Perimeter B-Series OCT system
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 17 2025
0mins
Should l Buy ?
Premarket Approval Application: Perimeter Medical Imaging AI has submitted a Premarket Approval application to the FDA for its next-generation Perimeter B-Series OCT system, which utilizes AI technology for breast-conserving surgeries in the U.S.
Pivotal Study Results: The pivotal trial for the B-Series OCT with ImgAssist AI 2.0 showed significant results, achieving a reduction in residual cancer during surgery and demonstrating improved surgical margin clarity, potentially reducing reoperation rates.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
